Search Results
Results found for "Bryan Roth"
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
Biased signaling is real but harder to exploit than expected GPR68 couples to both Gq and Gs, and the The group needed someone to visit Gilman's lab to learn radioligand binding — and he was the one with nothing And the answer was nothing." "We don't know what we don't know.
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
the beta2-adrenergic receptor (beta2AR)-G protein complex, team effort with long time collaborator Brian
- Our History | Dr. GPCR Ecosystem
Brian Kobilka , 2012 Nobel Laureate in Chemistry.
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
Some journals are beginning to accept negative data, and both agree this matters structurally. timelines 40:54 - Upcoming GPCR conferences in Leipzig and Dusseldorf Selected Quotes "It's like there's nothing
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
first described and when working on them was a high-risk research bet, the CGRP drug approvals are both drugs targeting that pathway can abolish chronic migraine entirely for some patients - while doing nothing
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
pride as much as a signal that the field recognized what real-time, live-cell measurement offers that nothing I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
In the early 2000s there were screening campaigns against these receptors, but nothing promising emerged If the receptor system and the tool are both unknowns, it becomes very difficult to interpret the results The worst thing you can do in science is nothing.
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
prone to activation, and resistant to pharmacological blockade - and why those properties have shaped both Bitterness and toxicity are not the same thing - and the field had to prove it A long-standing assumption in both rapid-assembly international collaboration that surveyed tens of thousands of patients and found that while both developing a recommendation system - trained on known receptor-ligand pairs and the structural properties of both Her work focuses on both sweet and bitter taste receptor GPCRs and her lab established the BitterDB .
- 14-Day Trial — Dr. GPCR University | Full Access for $49 | Dr. GPCR Ecosystem
Nothing held back. Nothing is restricted. What happens to my $49 if I become a member? It becomes a credit. Nothing is held back. You get everything Premium members have for 14 days. Can I start anytime?
- Finance is Science too: How Numbers Keep the Lights On with Chuck DeWeese & Joe St. Germain | Dr. GPCR Ecosystem
Both Chuck and Joe agree: accounting is like solving puzzles. Germain Networking: Relationship Over Transaction Both guests stress that business is built on relationships episode, Yamina and her guests underscore that finance and science share more than most people think —both
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
therapeutic targets beyond sensory biology The moment when open-access GPCR data integration improves both pharmacology, contributing as a professor, senior lecturer, editorial board member, and scientific officer in both
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
big pharma and biotech, encompassing functional assay development, GPCR internalization research, and both Awarded patents and a proven record in both target and pathway identification, his drive centers on integrating
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
They both discussed the intense competition in their home province, Quebec, and its impact on students Additionally, they both agreed on the importance of mentorship in building confidence, with Yamina sharing They both agreed on the value of these strategies.
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
In knockout mice, loss of CXCR3 abolishes response to both anti-PD-1 and anti-CTLA-4, reframing the receptor Both required trusting the data when the conceptual framework was telling the team they must be wrong Both landed in Nature and Cell respectively. 7. Team science is structural, not decorative.
- Yamina's Corner | Dr. GPCR Ecosystem
Discovery What Partners Say Here’s what it’s like to work together — from people I’ve supported on both Her involvement consistently elevates both the scientific discipline and the quality of portfolio-level , define clear go/no-go criteria, and integrate ADME and mechanistic assays in a way that reflected both
- Chemical Probes for GPCR Imaging and Internalization with Dr. Johannes Broichhagen | Dr. GPCR Ecosystem
assay systems, and why fluorescence-based assays paired with careful synthetic planning open doors for both –2016) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both
- Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem
She describes the shift as both technically disorienting and visually striking - a different relationship from an academic-industry collaboration that would not have produced the allosteric modulators without both academia stopped making sense 30:54 From Field Application Scientist to Product Manager 38:58 What both
- Dr. GPCR Board | Dr. GPCR Ecosystem
Maria Waldhoer "I am a pharmacologist with a ~30 years background in academia and industry, working both After a well needed break from the grind, I am now a scientific/business consultant for clients both
- Custom Molecules, Fluorescent Probes: When Chemists Think Like Biologists with Dr. Maria Majellaro from Celtarys | Dr. GPCR Ecosystem
GPCR ecosystem, contributing both expertise and tools that align directly with the needs of scientists central role in the development and validation of Celtarys’ proprietary synthetic technology and is both
- Mark Schmeizl | Dr. GPCR Ecosystem
He has successfully built numerous global life science, leadership teams, & works closely with both clients
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
such as the activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both
- When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. Ben Clements | Dr. GPCR Ecosystem
communication, and peer learning — especially from undergraduate trainees — shape his development as both In addition, he plans to continue studying how neuromodulators, both exogenous and endogenous, can influence
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
Thomas Südhof's lab — that a cell adhesion molecule and a GPCR, studied separately for over a decade, both On a colleague's suggestion, he recognized that both proteins had independently been shown to bind alpha-latrotoxin Südhof himself was skeptical; the field had studied both proteins for over a decade without making the
- Dr. Daniel Isom | Dr. GPCR Ecosystem
went on to earn a Ph.D. in Molecular Biophysics from Johns Hopkins University, followed by postdocs at both
- GPCR location matters with Dr. Gabriele Kockelkoren | Dr. GPCR Ecosystem
Gabriele Kockelkoren About Gabriele Kockelkoren I have a strong background in both physics and molecular
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
Excellerate is involved in several pre-clinical drug discovery projects for both GPCR and non-GPCR targets
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in
- Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
Both started as receptors with no known ligand, no known localization, and no reason to expect physiological as a postdoctoral fellow in the laboratory of Michael Caplan at Yale University, where she studied both
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
through which I gained an M.Sc. from Somerville College and a D.Phil. from Magdalen College Oxford, both




























